Longevity Biotech Company
Longevity Biotech, a Philadelphia, PA-based developer of a new class of therapeutics via artificial protein technology. Longevity Biotech focuses on pharmaceutical preparation. Its hybridtides are targeted biologic-like molecules which are highly-resistant to breakdown by natural digestive enzymesand tunable to very stable molecular structures.
.jpeg)
Technology:
Metabolic Disorders
Industry:
Small&Large Molecules
Headquarters:
Philadelphia, Pennsylvania, United States
Founded Date:
2010
Employees Number:
1-10
Investors Number:
2
Total Funding:
$836.4K
Estimated Revenue:
Less than $1M
Last Funding Type:
Grant
Register and Claim Ownership